Compare Neurocrine Biosciences Inc (NBIX) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Oatly Group AB - ADR — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Oatly Group AB - ADR trades at $9.85 (market cap $308.50M). The key difference: Neurocrine Biosciences Inc is far larger — about 56.4× Oatly Group AB - ADR's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals.
| NBIX | OTLY | |
|---|---|---|
Market Cap | $17.40B | $308.50M |
Sector | Health | Consumer Staples |
52-Week High | $180.55 | $18.54 |
52-Week Low | $123.10 | $8.03 |
Enterprise Value | $16.49B | $806.12M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
